QC
TMO icon

Quent Capital’s Thermo Fisher Scientific TMO Stock Holding History

Quent Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Sell
2,312
-455
-16% -$247K 0.08% 119
2025
Q4 		$1.6M Buy
2,767
+865
+45% +$489K 0.12% 103
2025
Q3 		$922K Buy
1,902
+43
+2% +$20K 0.08% 99
2025
Q2 		$754K Sell
1,859
-1
-0.1% -$418 0.07% 115
2025
Q1 		$926K Sell
1,860
-26
-1% -$14.1K 0.1% 92
2024
Q4 		$981K Hold
1,886
– – 0.1% 92
2024
Q3 		$1.17M Hold
1,886
– – 0.12% 101
2024
Q2 		$1.04M Buy
1,886
+19
+1% +$10.9K 0.11% 98
2024
Q1 		$1.09M Buy
1,867
+113
+6% +$63.4K 0.13% 96
2023
Q4 		$931K Sell
1,754
-2
-0.1% -$968 0.13% 97
2023
Q3 		$889K Sell
1,756
-9
-0.5% -$4.8K 0.14% 92
2023
Q2 		$921K Sell
1,765
-39
-2% -$21K 0.14% 85
2023
Q1 		$1.04M Buy
1,804
+48
+3% +$27.1K 0.18% 68
2022
Q4 		$967K Sell
1,756
-42
-2% -$22.3K 0.18% 76
2022
Q3 		$912K Buy
1,798
+45
+3% +$25.2K 0.19% 71
2022
Q2 		$952K Buy
1,753
+52
+3% +$28.6K 0.2% 66
2022
Q1 		$1M Buy
1,701
+663
+64% +$381K 0.19% 81
2021
Q4 		$693K Buy
+1,038
New +$648K 0.15% 116

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quent Capital's TMO Position: Q1 2026 in Review

Quent Capital reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q1 2026, selling an estimated $247K and leaving 2,312 shares worth $1.14M. The position accounts for 0.08% of the portfolio, ranked #119.

Quent Capital first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.6M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Quent Capital held 2,312 shares of Thermo Fisher Scientific worth $1.14M as of Q1 2026.
  • Quent Capital sold 455 Thermo Fisher Scientific shares in Q1 2026, an estimated $247K.
  • Thermo Fisher Scientific made up 0.08% of Quent Capital's portfolio in Q1 2026, its #119 holding.
  • Quent Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Thermo Fisher Scientific position peaked at $1.6M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.